Form 4: Clover Health CFO's Stock Transaction for Tax Obligations

Clover Health's CFO, Peter J. Kuipers, disposed of 217,382 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Summary

• Peter J. Kuipers, Chief Financial Officer of Clover Health Investments, Corp. (CLOV), disposed of 217,382 shares of Class A Common Stock on October 29, 2025.
• The disposition was made at a price of $3.64 per share.
• These shares were automatically withheld to cover tax obligations upon the vesting of 6.25% of time-based restricted stock units (RSUs).
• The original RSU grant occurred on April 29, 2024.
• Following this transaction, Peter J. Kuipers beneficially owns 5,915,209 shares of Class A Common Stock.
• The remaining RSUs are scheduled to vest in equal quarterly installments, with a final vesting date on April 29, 2028, contingent on continued service.

Sentiment

Score: 5

Explanation: This is a routine insider transaction for tax withholding upon RSU vesting and does not indicate a change in company fundamentals or management's outlook.

Future Outlook

The remaining restricted stock units granted to the Chief Financial Officer are scheduled to vest in equal quarterly installments, with a final vesting date on April 29, 2028, subject to continued service.

Industry Context

This filing represents a routine insider transaction related to executive compensation and tax obligations, which is a common occurrence across publicly traded companies when restricted stock units vest.

Stakeholder Impact

• Shareholders: This is a routine, non-discretionary transaction related to executive compensation and tax obligations, with minimal direct impact on the company's operational or financial performance.

Next Steps

• Continued vesting of remaining restricted stock units in equal quarterly installments until April 29, 2028, subject to the reporting person's continued service.

Key Dates

Recommendation

This Form 4 filing details a routine tax-related disposition of shares by the CFO upon RSU vesting and does not provide new information that would alter the fundamental investment thesis for Clover Health. It is a standard compensation event and does not warrant a change in investment recommendation based solely on this disclosure.

Keywords

Clover Health, CLOV, Form 4, Insider Transaction, CFO, Stock Vesting, Tax Withholding, Restricted Stock Units